Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1

Breast cancers display phenotypic and functional heterogeneity and several lines of evidence support the existence of cancer stem cells (CSCs) in certain breast cancers, a minor population of cells capable of tumor initiation and metastatic dissemination. Identifying factors that regulate the CSC phenotype is therefore important for developing strategies to treat metastatic disease. The Inhibitor of Differentiation Protein 1 (Id1) and its closely related family member Inhibitor of Differentiation 3 (Id3) (collectively termed Id) are expressed by a diversity of stem cells and are required for metastatic dissemination in experimental models of breast cancer. In this study, we show that ID1 is expressed in rare neoplastic cells within ER-negative breast cancers. To address the function of Id1 expressing cells within tumors, we developed independent murine models of Triple Negative Breast Cancer (TNBC) in which a genetic reporter permitted the prospective isolation of Id1+ cells. Id1+ cells are enriched for self-renewal in tumorsphere assays in vitro and for tumor initiation in vivo. Conversely, depletion of Id1 and Id3 in the 4T1 murine model of TNBC demonstrates that Id1/3 are required for cell proliferation and self-renewal in vitro, as well as primary tumor growth and metastatic colonization of the lung in vivo. Using combined bioinformatic analysis, we have defined a novel mechanism of Id protein function via negative regulation of the Roundabout Axon Guidance Receptor Homolog 1 (Robo1) leading to activation of a Myc transcriptional programme.

[1]  S. Lakhani,et al.  Id proteins promote a cancer stem cell phenotype in triple negative breast cancer via Robo1-dependent c-Myc activation , 2018, bioRxiv.

[2]  P. Muñoz,et al.  Cancer cell plasticity: Impact on tumor progression and therapy response. , 2018, Seminars in cancer biology.

[3]  K. Tew,et al.  MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer. , 2017, Cancer research.

[4]  K. Shokat,et al.  Drugging the 'undruggable' cancer targets , 2017, Nature Reviews Cancer.

[5]  G. Wahl,et al.  Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity , 2017, npj Breast Cancer.

[6]  R. Nair,et al.  The role of cancer stem cells in tumor heterogeneity and resistance to therapy. , 2017, Canadian journal of physiology and pharmacology.

[7]  Atique U. Ahmed,et al.  Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance , 2016, Journal of stem cell research & therapy.

[8]  Long Yu,et al.  E3 Ubiquitin Ligase RLIM Negatively Regulates c-Myc Transcriptional Activity and Restrains Cell Proliferation , 2016, PloS one.

[9]  Wen-Wei Chang,et al.  Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs , 2015, Oncotarget.

[10]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[11]  Jun Yu,et al.  The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers , 2015, BMC Cancer.

[12]  J. Knoblich,et al.  Mammary Stem Cell Self-Renewal Is Regulated by Slit2/Robo1 Signaling through SNAI1 and mINSC. , 2015, Cell reports.

[13]  Chih-Yang Wang,et al.  Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells , 2015, Nature.

[14]  Huikun Zhang,et al.  Low Expression of Slit2 and Robo1 is Associated with Poor Prognosis and Brain-specific Metastasis of Breast Cancer Patients , 2015, Scientific Reports.

[15]  Adam L Cohen,et al.  Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP , 2015, Proceedings of the National Academy of Sciences.

[16]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[17]  L. Aloia,et al.  Direct interaction between Id1 and Zrf1 controls neural differentiation of embryonic stem cells , 2015, EMBO reports.

[18]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[19]  W. S. Teo,et al.  ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  C. Perou,et al.  c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer , 2014, Oncogene.

[21]  X Wang,et al.  MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin , 2014, Oncogene.

[22]  A. Iavarone,et al.  The ID proteins: master regulators of cancer stem cells and tumour aggressiveness , 2014, Nature Reviews Cancer.

[23]  L. Norton,et al.  TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition. , 2013, Cell reports.

[24]  Jason I. Herschkowitz,et al.  Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts , 2013, Genome Biology.

[25]  Ming Li,et al.  The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. , 2013, Neoplasia.

[26]  K. Aldape,et al.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. , 2013, The Journal of clinical investigation.

[27]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[28]  King-Jen Chang,et al.  Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway. , 2012, Cancer research.

[29]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.

[30]  A. Krešo,et al.  ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. , 2012, Cancer cell.

[31]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[32]  G. Landberg,et al.  Cyclin D1, Id1 and EMT in breast cancer , 2011, BMC Cancer.

[33]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[34]  Jason I. Herschkowitz,et al.  Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells , 2011, Proceedings of the National Academy of Sciences.

[35]  Erika Pastrana,et al.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells. , 2011, Cell stem cell.

[36]  Jung Bok Lee,et al.  ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis , 2011, Journal of Cell Science.

[37]  J. Baselga,et al.  TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.

[38]  David R. Croucher,et al.  Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. , 2010, Cancer research.

[39]  G. Kong,et al.  Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex , 2010, Oncogene.

[40]  Jennifer A. Prescher,et al.  Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models , 2010, Proceedings of the National Academy of Sciences.

[41]  R. Benezra,et al.  Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth. , 2010, Cancer research.

[42]  Mei Zhang,et al.  Selective targeting of radiation-resistant tumor-initiating cells , 2010, Proceedings of the National Academy of Sciences.

[43]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[44]  Lin Zhang,et al.  KLF17 is a negative regulator of epithelial–mesenchymal transition and metastasis in breast cancer , 2009, Nature Cell Biology.

[45]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[46]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[47]  F. Bertucci,et al.  Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. , 2009, Cancer research.

[48]  F. Brunicardi,et al.  Smad3 mediates immediate early induction of Id1 by TGF-β , 2009, Cell Research.

[49]  J. Visvader,et al.  The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. , 2008, Cancer research.

[50]  T. Golub,et al.  Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells. , 2008, Blood.

[51]  Joseph,et al.  Imagable 4T1 model for the study of late stage breast cancer , 2008, BMC Cancer.

[52]  Jean-Marc Guinebretière,et al.  A six-gene signature predicting breast cancer lung metastasis. , 2008, Cancer research.

[53]  Daniel Medina,et al.  Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. , 2008, Cancer research.

[54]  Susan G Hilsenbeck,et al.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.

[55]  J. Bishop,et al.  Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response , 2008, Proceedings of the National Academy of Sciences.

[56]  Roger R. Gomis,et al.  TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4 , 2008, Cell.

[57]  D. Nolan,et al.  Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis , 2008, Science.

[58]  G. Kong,et al.  Id-1 regulates Bcl-2 and Bax expression through p53 and NF-κB in MCF-7 breast cancer cells , 2008, Breast Cancer Research and Treatment.

[59]  Edi Brogi,et al.  ID genes mediate tumor reinitiation during breast cancer lung metastasis , 2007, Proceedings of the National Academy of Sciences.

[60]  L. Nie,et al.  Maintenance Id1, but Not Id3, Directs Long-term Repopulating Hematopoietic Stem-cell , 2022 .

[61]  Aleksandra M. Michalowska,et al.  Transforming Growth Factor-β Can Suppress Tumorigenesis through Effects on the Putative Cancer Stem or Early Progenitor Cell and Committed Progeny in a Breast Cancer Xenograft Model , 2007 .

[62]  Alicia Zhou,et al.  Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers , 2007, Proceedings of the National Academy of Sciences.

[63]  Zhiyuan Hu,et al.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors , 2007, Genome Biology.

[64]  M. Simon,et al.  A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression , 2006, Proceedings of the National Academy of Sciences.

[65]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[66]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[68]  R. Sutherland,et al.  Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix–loop–helix protein Id1 , 2005, Oncogene.

[69]  W. Gerald,et al.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.

[70]  C. Restall,et al.  Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. , 2005, Molecular cancer research : MCR.

[71]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[72]  T. Martin,et al.  A novel orthotopic model of breast cancer metastasis to bone , 1999, Clinical & Experimental Metastasis.

[73]  Y. Itahana,et al.  Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[74]  G. Dontu,et al.  Stem cells in normal breast development and breast cancer , 2003, Breast Cancer Research.

[75]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[76]  J. Massagué,et al.  A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. , 2003, Molecular cell.

[77]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[78]  Paul J. Williams,et al.  Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma , 2000, Cancer.

[79]  C. Q. Lin,et al.  A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. , 2000, Cancer research.

[80]  Cheryl Jorcyk,et al.  The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma , 2000, Oncogene.

[81]  W. Gerald,et al.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts , 1999, Nature.

[82]  D. Trono,et al.  A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.

[83]  S. Ostrand-Rosenberg,et al.  Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. , 1998, Cancer research.

[84]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.